biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Stagliano's Neuron23 Raises Another $100 million

<< Previous

Bullboard Posts

Next >>

Comment by lovingoldon Mar 31, 2022 3:07pm

140 Views

Post# 34564211

RE:RE:RE:Stagliano's Neuron23 Raises Another $100 million

Finallytherock wrote: He's so desperate to show anything with this company that he's resorting to posting things unrelated to bioasis. There's nothing to say here. Not sure what the company was paying JD for given that there's nothing to say.

Who is paying you Finallytherock (someone who owns zero, nada, none, 0 shares in Bioasis) for your constant bashing of the company and its shareholders and former employees?

Someone should not have enough free time as you clearly do, for something that they shouldn't, theoretically, have a care or concern about.
Hence, you must have an ulterior motive.
Alas, you are a paid troll or want cheap shares.